Key Points
- David Sponsel, Alphatec's EVP, sold 988 shares on Dec. 8 at $21.45 for $21,192.60; he still holds 460,873 shares (a 0.21% decrease) after earlier large sales this fall including 70,000 shares on Oct. 24 and 137,445 shares on Sept. 18.
- EPS beat: Alphatec topped quarterly estimates on Oct. 30 with EPS of $0.03 vs. consensus -$0.06 and revenue of $196.5M (up 30.4% YoY), spurring analyst price-target raises and a consensus "Moderate Buy" rating with an average target of $22.45.
- Market snapshot: ATEC traded around $20.93 (up ~0.2%) with a market cap of $3.11B, a 52‑week range of $8.69–$22.66, and roughly 66% institutional ownership.
Alphatec Holdings, Inc. (NASDAQ:ATEC - Get Free Report) EVP David Sponsel sold 988 shares of Alphatec stock in a transaction that occurred on Monday, December 8th. The shares were sold at an average price of $21.45, for a total transaction of $21,192.60. Following the sale, the executive vice president directly owned 460,873 shares of the company's stock, valued at $9,885,725.85. This represents a 0.21% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink.
David Sponsel also recently made the following trade(s):
- On Friday, October 24th, David Sponsel sold 70,000 shares of Alphatec stock. The stock was sold at an average price of $16.18, for a total value of $1,132,600.00.
- On Friday, September 19th, David Sponsel sold 2,555 shares of Alphatec stock. The shares were sold at an average price of $15.34, for a total value of $39,193.70.
- On Thursday, September 18th, David Sponsel sold 137,445 shares of Alphatec stock. The stock was sold at an average price of $15.09, for a total value of $2,074,045.05.
Alphatec Stock Up 0.2%
Shares of ATEC traded up $0.03 during midday trading on Thursday, reaching $20.93. 150,246 shares of the stock were exchanged, compared to its average volume of 2,120,213. The company has a market capitalization of $3.11 billion, a P/E ratio of -20.07 and a beta of 1.08. The company has a current ratio of 1.99, a quick ratio of 1.24 and a debt-to-equity ratio of 43.02. Alphatec Holdings, Inc. has a 52 week low of $8.69 and a 52 week high of $22.66. The company's 50 day moving average is $18.18 and its two-hundred day moving average is $15.00.
Alphatec (NASDAQ:ATEC - Get Free Report) last released its quarterly earnings data on Thursday, October 30th. The medical technology company reported $0.03 earnings per share for the quarter, topping analysts' consensus estimates of ($0.06) by $0.09. The business had revenue of $196.50 million during the quarter, compared to analysts' expectations of $182.78 million. During the same period last year, the company earned ($0.28) earnings per share. The firm's revenue was up 30.4% compared to the same quarter last year. On average, sell-side analysts anticipate that Alphatec Holdings, Inc. will post -1.08 earnings per share for the current year.
Wall Street Analysts Forecast Growth
A number of equities analysts have recently issued reports on ATEC shares. Piper Sandler reiterated an "overweight" rating and set a $25.00 price objective (up from $20.00) on shares of Alphatec in a research note on Friday, October 31st. Canaccord Genuity Group increased their target price on Alphatec from $20.00 to $25.00 and gave the company a "buy" rating in a research report on Friday, October 31st. Lake Street Capital set a $25.00 price target on Alphatec and gave the company a "buy" rating in a report on Friday, October 31st. Needham & Company LLC upped their price objective on Alphatec from $16.00 to $22.00 and gave the stock a "buy" rating in a research note on Friday, October 31st. Finally, Barclays lifted their target price on Alphatec from $22.00 to $23.00 and gave the company an "overweight" rating in a research note on Monday, November 3rd. Nine analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $22.45.
View Our Latest Stock Report on Alphatec
Institutional Investors Weigh In On Alphatec
A number of large investors have recently modified their holdings of ATEC. Tudor Investment Corp ET AL raised its position in shares of Alphatec by 608.4% in the 3rd quarter. Tudor Investment Corp ET AL now owns 900,491 shares of the medical technology company's stock valued at $13,093,000 after purchasing an additional 773,367 shares during the last quarter. CIBC Bancorp USA Inc. acquired a new position in Alphatec during the 3rd quarter valued at approximately $180,000. Oberweis Asset Management Inc. purchased a new position in shares of Alphatec in the third quarter worth $6,705,000. Dark Forest Capital Management LP lifted its stake in shares of Alphatec by 61.9% during the third quarter. Dark Forest Capital Management LP now owns 120,712 shares of the medical technology company's stock worth $1,755,000 after buying an additional 46,167 shares during the period. Finally, XTX Topco Ltd acquired a new stake in shares of Alphatec during the third quarter worth $1,300,000. Hedge funds and other institutional investors own 66.35% of the company's stock.
About Alphatec
(
Get Free Report)
Alphatec Holdings, Inc, a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. It manufactures and sells implants and instruments through third-party suppliers. The company offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application, which leverages EOS technology to more quickly quantify alignment parameters on a mobile device; SafeOp Neural InformatiX System that automates electromyographic and somatosensory evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
